Ivermectina Teva

Ivermectin, the active ingredient in Ivermectina Teva, is an antiparasitic (macrocyclic lactone) presented as an oral formulation for systemic use. It is employed to treat a range of parasitic infections, including river blindness, strongyloidiasis, scabies, lice infestation and other helminthic diseases in appropriate patient populations.

GNH USA supplies Ivermectina Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ivermectin is an antiparasitic agent that acts on a variety of helminth and ectoparasite infections. - Onchocerciasis: reduces microfilarial load and helps prevent ocular damage. - Strongyloidiasis: eliminates intestinal larvae and prevents disseminated disease. - Scabies: eradicates Sarcoptes scabiei mites, relieving skin lesions. - Pediculosis: kills head‑lice and nits, stopping infestation spread. - Other helminth infections: provides broad‑spectrum activity against several nematodes.

Ivermectin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Dizziness: transient light‑headedness. - Pruritus: itching at the site of parasite death. - Headache: mild tension‑type pain. - Abdominal pain: cramping or discomfort. - Diarrhea: loose stools.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction requiring immediate care. - Hepatic injury: elevated liver enzymes or jaundice. - Neurologic toxicity: seizures, ataxia, or altered mental status. - Anaphylaxis: acute allergic response with respiratory compromise. - Vision changes: blurred vision or optic neuritis. - Severe skin rash: extensive erythema or bullous lesions.

Before prescribing Ivermectina Teva, clinicians should consider several safety measures. - Assess hypersensitivity: confirm no known allergy to ivermectin or excipients. - Evaluate liver function: use caution in patients with hepatic impairment. - Review concomitant CNS drugs: avoid additive neurotoxicity. - Consider pregnancy status: weigh benefits against potential risks. - Monitor for drug‑induced skin reactions: educate patients on warning signs. - Store at room temperature below 25°C: keep in the original packaging, protect from moisture and light.

Ivermectin may interact with other medicines, requiring attention to dosage and monitoring.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase ivermectin plasma levels. - P‑gp inhibitors (e.g., verapamil, quinidine): can raise systemic exposure. - Co‑administration with other neurotoxic antiparasitics: risk of additive CNS effects.

Moderate Interactions (Monitor Closely): - Warfarin: potential for enhanced anticoagulant effect. - CNS depressants (e.g., benzodiazepines, opioids): monitor for excessive sedation. - Antifungal azoles (non‑CYP3A4): may modestly affect metabolism.